Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 48, Pages e2103585118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-11-25
DOI
10.1073/pnas.2103585118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ER-directed TREX1 limits cGAS activation at micronuclei
- (2021) Lisa Mohr et al. MOLECULAR CELL
- cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing
- (2021) Wen Zhou et al. MOLECULAR CELL
- A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity
- (2020) Louisa Nelson et al. Nature Communications
- Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence
- (2020) Bo Zhao et al. Nature Communications
- Mechanisms generating cancer genome complexity from a single cell division error
- (2020) Neil T. Umbreit et al. SCIENCE
- nucleAIzer: A Parameter-free Deep Learning Framework for Nucleus Segmentation Using Image Style Transfer
- (2020) Reka Hollandi et al. Cell Systems
- Role of Post-Translational Modifications of cGAS in Innate Immunity
- (2020) Yakun Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural mechanism of cGAS inhibition by the nucleosome
- (2020) Ganesh R. Pathare et al. NATURE
- BAF restricts cGAS on nuclear DNA to prevent innate immune activation
- (2020) Baptiste Guey et al. SCIENCE
- Structural basis for the inhibition of cGAS by nucleosomes
- (2020) Tomoya Kujirai et al. SCIENCE
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- SLC19A1 Is an Importer of the Immunotransmitter cGAMP
- (2019) Christopher Ritchie et al. MOLECULAR CELL
- Structure of the Human cGAS–DNA Complex Reveals Enhanced Control of Immune Surveillance
- (2018) Wen Zhou et al. CELL
- Chromosomal instability drives metastasis through a cytosolic DNA response
- (2018) Samuel F. Bakhoum et al. NATURE
- Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
- (2018) Assaf Marcus et al. IMMUNITY
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Anti-mitotic agents: Are they emerging molecules for cancer treatment?
- (2017) Larissa Siqueira Penna et al. PHARMACOLOGY & THERAPEUTICS
- Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer
- (2017) Jacqueline M. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- cGAS is essential for the antitumor effect of immune checkpoint blockade
- (2017) Hua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
- (2017) T. J. Mitchison et al. Open Biology
- Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity
- (2016) A. M. Wengner et al. MOLECULAR CANCER THERAPEUTICS
- Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining
- (2016) Peter Ly et al. NATURE CELL BIOLOGY
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- The presence of extra chromosomes leads to genomic instability
- (2016) Verena Passerini et al. Nature Communications
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- Chromothripsis and Kataegis Induced by Telomere Crisis
- (2015) John Maciejowski et al. CELL
- DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity
- (2015) Anetta Härtlova et al. IMMUNITY
- DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway
- (2015) L. Lau et al. SCIENCE
- A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
- (2015) Christian O. de Groot et al. Frontiers in Oncology
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei
- (2013) Emily M. Hatch et al. CELL
- Oxidative Damage of DNA Confers Resistance to Cytosolic Nuclease TREX1 Degradation and Potentiates STING-Dependent Immune Sensing
- (2013) Nadine Gehrke et al. IMMUNITY
- Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
- (2013) Andrea Ablasser et al. NATURE
- DNA breaks and chromosome pulverization from errors in mitosis
- (2012) Karen Crasta et al. NATURE
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- Mitosis as an anti-cancer target
- (2011) A Janssen et al. ONCOGENE
- Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
- (2010) Anne M. Traynor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs
- (2008) Karen E. Gascoigne et al. CANCER CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started